Higher Starting Dose and Rapid Attainment of Tacrolimus Blood Levels With Envarsus Vs. Prograf Is Not Associated With Increased Toxicity: Exploratory Analysis of a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized, Prospective Study of Envarsus (Once-Daily MeltDose Tacrolimus Tablets) Vs. Prograf (Twice-Daily Tacrolimus Capsules)

被引：0

作者：

Tedesco Silva, H., Jr. ^{[1
]}

Bunnapradist, S. ^{[2
]}

Steinberg, S. ^{[3
]}

机构：

[1] Hosp Rim, Sao Paulo, Brazil

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] Calif Inst Renal Res, San Diego, CA USA

来源：

TRANSPLANTATION | 2014年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A207

引用

页码：458 / 458

页数：1

共 16 条

[11] Pulse Wave Velocity Amongst African-American Kidney Transplant Recipients Randomized to Once-Daily MeltDose Tacrolimus Tablets (Envarsus XR) vs. Traditional Twice-Daily Tacrolimus Capsules: Exploratory Results from a Phase III Trial.
Trofe-Clark, J.
Townsend, R.
Neubauer, R.
Lim, M.
Callahan, L.
Bloom, R.
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 797 - 797
[12] Comparison of Pharmacokinetics and Pharmacogenomics of Once-Daily Extended-Release MeltDose® Tacrolimus Tablets (Envarsus® XR) Vs. Twice-Daily Tacrolimus Capsules in Stable African American Kidney Transplant Patients: A Randomized Cross-Over Study
Trofe-Clark, J.
Brennan, D.
West-Thielke, P.
Milone, M.
Lim, M.
Bloom, R.
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
[13] DRUG DOSE, DOSE ADJUSTMENTS, AND RENAL FUNCTION AMONG DE NOVO LIVER TRANSPLANT RECIPIENTS RANDOMIZED TO ENVARSUS® TABLETS ONCE-DAILY VS. PROGRAF® CAPSULES TWICE-DAILY: RESULTS FROM A PHASE 2 STUDY
Dubay, Derek
Chapman, William
Teperman, Lewis
TRANSPLANT INTERNATIONAL, 2015, 28 : 73 - 73
[14] Lower Treatment Failures in Blacks and Older DeNovo and Stable Kidney Transplant Recipients Treated With Envarsus Once-Daily MeltDose Tablets Vs. Twice-Daily Prograf Capsules: A Pooled Subgroup Analysis of Two Phase 3 Trials
Bunnapradist, S.
Alloway, R.
West-Thielke, P.
Denny, J.
Mulgaonkar, S.
TRANSPLANTATION, 2014, 98 : 459 - 460
[15] Lower Treatment Failures in Blacks and Older DeNovo and Stable Kidney Transplant Recipients Treated With Envarsus Once-Daily MeltDose Tablets Vs. Twice-Daily Prograf Capsules: A Pooled Subgroup Analysis of Two Phase 3 Trials.
Bunnapradist, S.
Alloway, R.
West-Thielke, P.
Denny, J.
Mulgaonkar, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 459 - 460
[16] A Phase 3, Double-Blind, Multi-Center, Non-Inferiority, Randomized Study To Examine the Efficacy and Safety of LCP-Tacro™ Tablets, Once Daily, Compared to Prograf® Capsules, Twice Daily, in Combination with Mycophenolate Mofetil in De Novo Adult Kidney Transplantation: Baseline Characteristics.
Rostaing, L.
Budde, K.
Bunnapradist, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 339 - 339

← 1 2 →